Sinovac Biotech Ltd. (SVA) Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results  
4/18/2013 6:58:09 AM

BEIJING, April 18, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of vaccines in China, announced today its unaudited fourth quarter and full year financial results for the period ended December 31, 2012.

Financial Highlights
    -- Total sales were $19.0 million for the fourth quarter of 2012, a decrease of 10.4% from $21.1 million in the same period of 2011.